Genomics Collaborative Inc.
www.genomicsinc.com
Latest From Genomics Collaborative Inc.
Deal Statistics Quarterly, Q2 2004
Statistical review compiled from our Strategic Transactions database including financings by type (IPO, private placement etc.); financings by sector (surgical equipment, implantable devices, etc.); alliances by therapeutic category (cardiovascular, orthopedic, etc.); alliances by industry segment (biomaterials, monitoring equipment, etc. ); for three separate industries: medical devices, in vitro diagnostics, and pharmaceuticals/biotechnology.
Fibromyalgia: The Newest Psychiatric Market
Cypress Bioscience has reinvented itself in the past year to focus on the development of drugs for fibromyalgia syndrome, a mysterious disease characterized by pain and sleeplessness in the absence of measurable pathophysiological features.
Biorepositories
Despite the in silico research ideals of many genomicists, no one has yet found a way around the basic requirement for using human tissue in gene expression studies-a broad array of it, well characterized, from healthy and diseased patients, and from world populations at large. That's why start-ups, drug discovery firms and others are creating a new resource: biorepositories--banks of tissue samples and data to serve the diagnostic, pharmaceutical and tissue engineering industries. As providers of services and products to research-based companies, these companies believe they are operating in a market that ranges from $500 million to $5 billion.
Genomics Collaborative Inc.
Genomics Collaborative Inc. looks like two distinct businesses: a functional genomics company in Cambridge, MA and a clinical research organization in Blue Bell, Pennsylvania. But they are really two halves of a single drug discovery company, says Michael Pellini, MD, CEO; one that possesses the analytical tools for genetic association studies and biological analysis and the patient biological samples to back them up.
Company Information
- Industry
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Genomics Collaborative Inc.
- Senior Management
-
Rick Episcopo, Pres.
John Boyce, Sr. Dir., Bus. Dev. - Contact Info
-
Genomics Collaborative Inc.
Phone: (484) 530-9050
99 Erie St.
Cambridge, MA 02139
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genomics Collaborative Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice